Metraipolis › archive › dc_bc2ac6346902

Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646844
DOI
10.3389/fimmu.2026.1731123
License (as archived)
solo-consultazione
Archived
2026-11-06T15:21:54.510Z
SHA-256 of the archived text
31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54
Stable URL of this page
https://metraipolis.com/documento/dc_bc2ac6346902

How to cite

Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844 — Europe PMC (en), https://europepmc.org/article/MED/41646844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc2ac6346902 (Metraipolis archive dc_bc2ac6346902, sha256 31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54)
BibTeX
@misc{dcbc2ac6346902,
  title = {Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646844},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc2ac6346902; sha256 31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646844. Agents can read the archived copy with the MCP tool read_document.